Biomarin Pharmaceutical (BMRN) FCF Margin Growth (1y) (2010 - 2026)
Biomarin Pharmaceutical (BMRN) FCF Margin Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,187.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Biomarin Pharmaceutical | 11.33 Bn | 9.11 Bn | 571.21 Mn | 491.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 491.00 |
| Dec 31, 2025 | -1,549.00 |
| Sep 30, 2025 | 1,399.00 |
| Jun 30, 2025 | 916.00 |
| Mar 31, 2025 | 1,794.00 |
| Dec 31, 2024 | 1,231.00 |
| Sep 30, 2024 | 1,458.00 |
| Jun 30, 2024 | -125.00 |
| Mar 31, 2024 | 1,971.00 |
| Dec 31, 2023 | 3,342.00 |
| Sep 30, 2023 | -1,928.00 |
| Jun 30, 2023 | -271.00 |
| Mar 31, 2023 | -220.00 |
| Dec 31, 2022 | -2,461.00 |
| Sep 30, 2022 | 835.00 |
| Jun 30, 2022 | -400.00 |
| Mar 31, 2022 | -3,240.00 |
| Dec 31, 2021 | 926.00 |
| Sep 30, 2021 | 548.00 |
| Jun 30, 2021 | 1,639.00 |